Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsDr. Sally Tucker has spoken on 1 investor event across 1 company, most recently for Opus Genetics, Inc. on September 9, 2026. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“I am pleased to present the Cohort 1 data from our Phase 1-2 clinical trial evaluating OPGX Best 1 in late-stage participants with Best 1 disease. We are very encouraged by these results and have received positive feedback on this data from our medical advisors.”
Transcript header (unverified)
Biotechnology · Healthcare
